{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:31:31Z","timestamp":1790400691282,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1023-7","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T08:02:27Z","timestamp":1550736147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising"],"prefix":"10.1186","volume":"14","author":[{"given":"Bradley","family":"Power","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih M.","family":"Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Introne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshi","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-8918","authenticated-orcid":false,"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"1023_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-2-43","volume":"2","author":"K Gr\u00f8nskov","year":"2007","unstructured":"Gr\u00f8nskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43.","journal-title":"Orphanet J Rare Dis"},{"key":"1023_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genom.9.081307.164303","volume":"9","author":"M Huizing","year":"2008","unstructured":"Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet. 2008;9:359\u201386.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1023_CR3","volume-title":"GeneReviews","author":"M Huizing","year":"2017","unstructured":"Huizing M, Malicdan MCV, Gochuico BR, Gahl WA. Hermansky-Pudlak Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle: University of Washington; 2017."},{"key":"1023_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/humu.22315","volume":"34","author":"DR Simeonov","year":"2013","unstructured":"Simeonov DR, Wang X, Wang C, Sergeev Y, Dolinska M, Bower M, et al. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Hum Mut. 2013;34:827\u201335.","journal-title":"Hum Mut."},{"key":"1023_CR5","doi-asserted-by":"publisher","first-page":"e0125651","DOI":"10.1371\/journal.pone.0125651","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wang Z, Chen M, Fan N, Yang J, Liu L, et al. Mutational analysis of the TYR and OCA2 genes in four Chinese families with oculocutaneous albinism. PLoS One. 2015;10:e0125651.","journal-title":"PLoS One"},{"key":"1023_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1212\/WNL.0000000000002551","volume":"86","author":"WJ Introne","year":"2016","unstructured":"Introne WJ, Westbroek W, Cullinane AR, Groden CA, Bhambhani V, Golas GA, et al. Neurologic involvement in patients with atypical Chediak-Higashi disease. Neurol. 2016;86:1320\u20138.","journal-title":"Neurol"},{"key":"1023_CR7","volume-title":"GeneReviews","author":"WJ Introne","year":"2015","unstructured":"Introne WJ, Westbroek W, Golas GA, Adams D. Chediak-Higashi syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle: University of Washington; 2015."},{"key":"1023_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0749.2005.00289.x","volume":"19","author":"ML Wei","year":"2006","unstructured":"Wei ML. Hermansky\u2013Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Melanoma Res. 2006;19:19\u201342.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1023_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","volume":"338","author":"WA Gahl","year":"1998","unstructured":"Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky\u2013Pudlak syndrome). New Engl J Med. 1998;338:1258\u201365.","journal-title":"New Engl J Med"},{"key":"1023_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/bjh.14390","volume":"176","author":"A Gil-Krzewska","year":"2017","unstructured":"Gil-Krzewska A, Murakami Y, Peruzzi G, O'Brien KJ, Merideth MA, Cullinane AR, et al. Natural killer cell activity and dysfunction in Hermansky-Pudlak syndrome. Brit J Haematol. 2017;176:118\u201323.","journal-title":"Brit J Haematol"},{"key":"1023_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2119\/molmed.2011.00198","volume":"18","author":"BR Gochuico","year":"2012","unstructured":"Gochuico BR, Huizing M, Golas GA, Scher CD, Tsokos M, Denver SD, et al. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease. Mol Med. 2012;18:56.","journal-title":"Mol Med"},{"key":"1023_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13023-018-0780-z","volume":"13","author":"M Hengst","year":"2018","unstructured":"Hengst M, Naehrlich L, Mahavadi P, Grosse-Onnebrink J, Terheggen-Lagro S, Skanke LH, et al. Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood. Orphanet J Rare Dis. 2018;13:42.","journal-title":"Orphanet J Rare Dis."},{"key":"1023_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1203\/00006450-200202000-00006","volume":"51","author":"M Huizing","year":"2002","unstructured":"Huizing M, Scher CD, Strovel E, Fitzpatrick DL, Hartnell LM, Anikster Y, et al. Nonsense mutations in ADTB3A cause complete deficiency of the \u03b23A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Ped Res. 2002;51:150.","journal-title":"Ped Res"},{"key":"1023_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00439-003-0933-5","volume":"113","author":"PD Anderson","year":"2003","unstructured":"Anderson PD, Huizing M, Claassen DA, White J, Gahl WA. Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet. 2003;113:10\u20137.","journal-title":"Hum Genet"},{"key":"1023_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.117.1.129","volume":"117","author":"M Brantly","year":"2000","unstructured":"Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest. 2000;117:129\u201336.","journal-title":"Chest"},{"key":"1023_CR16","doi-asserted-by":"crossref","unstructured":"Gronskov K, Br\u00f8ndum-Nielsen K, Lorenz B, Preising MN. Clinical utility gene card for: Oculocutaneous albinism. Eur J Hum Genet. 2014;22.","DOI":"10.1038\/ejhg.2013.307"},{"key":"1023_CR17","volume-title":"GeneReviews","author":"RA Lewis","year":"2013","unstructured":"Lewis RA. Oculocutaneous Albinism Type 1. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle: University of Washington; 2013."},{"key":"1023_CR18","volume-title":"Hermansky-Pudlak syndrome","author":"Orphanet","year":"2010","unstructured":"Orphanet. Hermansky-Pudlak syndrome. 2010."},{"key":"1023_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng576","volume":"28","author":"Y Anikster","year":"2001","unstructured":"Anikster Y, Huizing M, White J, Shevchenko YO, Fitzpatrick DL, Touchman JW, et al. Mutation of a new gene causes a unique form of Hermansky\u2013Pudlak syndrome in a genetic isolate of Central Puerto Rico. Nat Genet. 2001;28:376\u201380.","journal-title":"Nat Genet"},{"key":"1023_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/13816819009020986","volume":"11","author":"CJ Witkop","year":"1990","unstructured":"Witkop CJ, Almadovar C, Pineiro B, Babcock MN. Hermansky-Pudlak syndrome (HPS): an epidemiologic study. Ophthal Paediat Genet. 1990;11:245\u201350.","journal-title":"Ophthal Paediat Genet"},{"key":"1023_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.jid.5700034","volume":"126","author":"PJ Santiago Borrero","year":"2006","unstructured":"Santiago Borrero PJ, Rodr\u00edguez-P\u00e9rez Y, Renta JY, Izquierdo NJ, del Fierro L, Munoz D, et al. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky\u2013Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J Investig Dermatol. 2006;126:85\u201390.","journal-title":"J Investig Dermatol"},{"key":"1023_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/(SICI)1098-1004(199912)14:6<542::AID-HUMU14>3.0.CO;2-3","volume":"14","author":"CH Tsai","year":"1999","unstructured":"Tsai CH, Tsai FJ, Wu JY, Lin SP, Chang JG, Yang CF, et al. Insertion\/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan. Hum Mut. 1999;14:542.","journal-title":"Hum Mut"},{"key":"1023_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdermsci.2011.02.009","volume":"62","author":"A Wei","year":"2011","unstructured":"Wei A, Yang X, Lian S, Li W. Implementation of an optimized strategy for genetic testing of the Chinese patients with oculocutaneous albinism. J Dermatol Sci. 2011;62:124\u20137.","journal-title":"J Dermatol Sci"},{"key":"1023_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/pcmr.12534","volume":"29","author":"A Wei","year":"2016","unstructured":"Wei A, Yuan Y, Bai D, Ma J, Hao Z, Zhang Y, et al. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients. Pigment Cell Melanoma Res. 2016;29:702\u20136.","journal-title":"Pigment Cell Melanoma Res."},{"key":"1023_CR25","first-page":"8409","volume":"17","author":"W Sun","year":"2018","unstructured":"Sun W, Shen Y, Shan S, Han L, Li Y, Zhou Z, et al. Identification of TYR mutations in patients with oculocutaneous albinism. Mol Med Reports. 2018;17:8409\u201313.","journal-title":"Mol Med Reports"},{"key":"1023_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1086\/301757","volume":"62","author":"J Oh","year":"1998","unstructured":"Oh J, Ho L, Ala-Mello S, Amato D, Armstrong L, Bellucci S, et al. Mutation analysis of patients with Hermansky\u2013Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet. 1998;62:593\u20138.","journal-title":"Am J Hum Genet"},{"key":"1023_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/humu.9097","volume":"20","author":"CR Hermos","year":"2002","unstructured":"Hermos CR, Huizing M, Kaiser-Kupfer M, Gahl WA. Hermansky-Pudlak syndrome type 1: gene organization, new mutations, and clinical\/molecular review of non-Puerto Rican cases. Hum Mut. Mutations in brief #568. 2002;20:482\u201390.","journal-title":"Hum Mut. Mutations in brief #568"},{"key":"1023_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jdermsci.2008.07.002","volume":"53","author":"Y Wang","year":"2009","unstructured":"Wang Y, Guo X, Li W, Lian S. Four novel mutations of TYR gene in Chinese OCA1 patients. J Dermatol Sci. 2009;53:80\u20131.","journal-title":"J Dermatol Sci"},{"key":"1023_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1469-1809.2006.00247.x","volume":"70","author":"M Chaki","year":"2006","unstructured":"Chaki M, Sengupta M, Mukhopadhyay A, Subba Rao I, Majumder PP, Das M, et al. OCA1 in different ethnic groups of India is primarily due to founder mutations in the tyrosinase gene. Ann Hum Genet. 2006;70:623\u201330.","journal-title":"Ann Hum Genet"},{"key":"1023_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0161-6420(88)33152-0","volume":"95","author":"CG Summers","year":"1988","unstructured":"Summers CG, Knobloch WH, Witkop CJ Jr, King RA. Hermansky-Pudlak syndrome: ophthalmic findings. Ophthalmol. 1988;95:545\u201354.","journal-title":"Ophthalmol"},{"key":"1023_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2350\/15-11-1733-OA.1","volume":"19","author":"V Sorokin","year":"2016","unstructured":"Sorokin V, Alkhoury R, Al-Rawabdeh S, Houston RH, Thornton D, Kerlin B, et al. Reference range of platelet delta granules in the pediatric age group: An ultrastructural study of platelet whole mount preparations from healthy volunteers. Ped Develop Pathol. 2016;19:498\u2013501.","journal-title":"Ped Develop Pathol."},{"key":"1023_CR32","first-page":"327","volume":"16","author":"C Witkop","year":"1979","unstructured":"Witkop C. Albinism: hematologic-storage disease, susceptibility to skin cancer, and optic neuronal defects shared in all types of oculocutaneous and ocular albinism. The Alabama J Med Sci. 1979;16:327\u201330.","journal-title":"The Alabama J Med Sci"},{"key":"1023_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ymgme.2018.07.012","volume":"125","author":"KJ O'Brien","year":"2018","unstructured":"O'Brien KJ, Introne WJ, Akal O, Akal T, Barbu A, McGowan MP, Merideth MA, Seward SL Jr, Gahl WA, Gochuico BR. Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis. Mol Genet Metab. 2018;125:168\u201373.","journal-title":"Mol Genet Metab"},{"key":"1023_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","volume":"76","author":"WA Gahl","year":"2002","unstructured":"Gahl WA, Brantly M, Troendle J, Avila NA, Padua A, Montalvo C, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metabol. 2002;76:234\u201342.","journal-title":"Mol Genet Metabol."},{"key":"1023_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","volume":"103","author":"K O'Brien","year":"2011","unstructured":"O'Brien K, Troendle J, Gochuico BR, Markello TC, Salas J, Cardona H, et al. Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis. Mol Genet Metabol. 2011;103:128\u201334.","journal-title":"Mol Genet Metabol"},{"key":"1023_CR36","doi-asserted-by":"publisher","first-page":"e0194193","DOI":"10.1371\/journal.pone.0194193","volume":"13","author":"S El-Chemaly","year":"2018","unstructured":"El-Chemaly S, O\u2019Brien KJ, Nathan SD, Weinhouse GL, Goldberg HJ, Connors JM, et al. Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. PLoS One. 2018;13:e0194193.","journal-title":"PLoS One"},{"key":"1023_CR37","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.healun.2004.11.015","volume":"24","author":"DJ Lederer","year":"2005","unstructured":"Lederer DJ, Kawut SM, Sonett JR, Vakiani E, Seward SL Jr, White JG, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant. 2005;24:1697\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"1023_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/B978-0-12-397164-7.00136-1","volume":"126","author":"CH Miller","year":"2013","unstructured":"Miller CH. Laboratory diagnosis of platelet function defects. Transfusion Med Hemost. 2013;126:849\u201354.","journal-title":"Transfusion Med Hemost"},{"key":"1023_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1309\/AJCP9IPR1TFLUAGM","volume":"136","author":"M Pai","year":"2011","unstructured":"Pai M, Wang G, Moffat KA, Liu Y, Seecharan J, Webert K, et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol. 2011;136:350\u20138.","journal-title":"Am J Clin Pathol"},{"key":"1023_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0046-8177(85)80230-6","volume":"16","author":"RA Schinella","year":"1985","unstructured":"Schinella RA, Greco MA, Garay SM, Lackner H, Wolman SR, Fazzini EP. Hermansky-Pudlak syndrome: a clinicopathologic study. Hum Pathol. 1985;16:366\u201376.","journal-title":"Hum Pathol"},{"key":"1023_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ajh.2830260403","volume":"26","author":"CJ Witkop","year":"1987","unstructured":"Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol. 1987;26:305\u201311.","journal-title":"Am J Hematol"},{"key":"1023_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12959-016-0123-z","volume":"14","author":"A Magnette","year":"2016","unstructured":"Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49.","journal-title":"Thromb J"},{"key":"1023_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jdermsci.2009.07.007","volume":"56","author":"A Wei","year":"2009","unstructured":"Wei A, Lian S, Wang L, Li W. The first case report of a Chinese Hermansky-Pudlak syndrome patient with a novel mutation on HPS1 gene. J Dermatol Sci. 2009;56:130\u20132.","journal-title":"J Dermatol Sci"},{"key":"1023_CR44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200901-0023OC","volume":"180","author":"FN Rouhani","year":"2009","unstructured":"Rouhani FN, Brantly ML, Markello TC, Helip-Wooley A, O'brien K, Hess R, et al. Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. Am J Respir Crit Care Med. 2009;180:1114\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"1023_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymgme.2016.08.009","volume":"119","author":"KJ O'Brien","year":"2016","unstructured":"O'Brien KJ, Lozier J, Cullinane AR, Osorio B, Nghiem K, Speransky V, et al. Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism. Mol Genet Metabol. 2016;119:284\u20137.","journal-title":"Mol Genet Metabol."},{"key":"1023_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ymgme.2017.02.007","volume":"120","author":"MM Bryan","year":"2017","unstructured":"Bryan MM, Tolman NJ, Simon KL, Huizing M, Hufnagel RB, Brooks BP, et al. Clinical and molecular phenotyping of a child with Hermansky-Pudlak syndrome-7, an uncommon genetic type of HPS. Mol Genet Metabol. 2017;120:378\u201383.","journal-title":"Mol Genet Metabol."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1023-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:08:50Z","timestamp":1582225730000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1023-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1023-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients were admitted to the National Institutes of Health under protocols 76-HG-0238 (Clinical Trials number NCT00369421; Diagnosis and Treatment of Patients with Inborn Errors of Metabolism or Other Genetic Disorders), and\/or 95-HG-0193 (Clinical Trials number NCT00001456; Clinical and Basic Investigations into Hermansky-Pudlak Syndrome), which were approved by the institutional review board of the National Human Genome Research Institute. Patients\u2019 parents provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patients\u2019 parents at study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}